Valeant Pharmaceuticals (NYSE: VRX) confirmed a deal Monday to acquire privately-equity owned Bausch + Lomb Holdings Incorporated for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE